Long-term outcomes (>5-year follow-up) with porcine acellular dermal matrix (Permacol™) in incisional hernias at risk for infection

Keyphrases

• Infection Risk 100%
• 5-year Follow-up 100%
• Incisional Hernia 100%
• Permacol 100%
• Porcine Acellular Dermal Matrix 100%
• Sublay 100%
• Hernia Recurrence 75%
• Reinforced 75%
• Recurrence Rate 50%
• Seroma 50%
• Primary Closure 50%
• Onlay 50%
• Mesh Infection 50%
• Elective Operation 50%
• High Risk 25%
• Patient-physician 25%
• Wound Infection 25%
• Infection Rate 25%
• Clinical High Risk 25%
• Fascial 25%
• Clean-contaminated 25%
• Follow-up Examination 25%
• Early Complications 25%
• Hernia Repair 25%
• Abdominal Wall Reconstruction 25%
• Infection Recurrence 25%
• Wound Dehiscence 25%
• Unsatisfactory Outcome 25%
• Bioprosthesis 25%
• Dehiscence 25%
• Reported Incidence 25%
• Infected Wound 25%
• Non-elective 25%
• Ventral Hernia 25%
• Clean Contaminated Wound 25%

Medicine and Dentistry

• Infection 100%
• Acellular Dermal Matrix 100%
• Incisional Hernia 100%
• Surgical Mesh 100%
• Recurrent Disease 66%
• Wound Infection 50%
• Hernia 50%
• Recurrence Risk 33%
• Seroma 33%
• Prosthetics 16%
• Abdominal Wall Hernia 16%
• Hernioplasty 16%
• Abdominal Wall 16%
• Wound Dehiscence 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Pig 100%
• Incisional Hernia 100%
• Recurrent Disease 66%
• Hernia 66%
• Wound Infection 50%
• Recurrence Risk 33%
• Seroma 33%
• Abdominal Wall Hernia 16%
• Wound Dehiscence 16%